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Stimulation of growth factor signaling has been impli-
cated in the development of invasive phenotypes and
the activation of p21-activated kinase (Pak1) in human
breast cancer cells (Adam, L., Vadlamudi, R.,
Kondapaka, S. B., Chernoff, J., Mendelsohn, J., and Ku-
mar, R. (1998) J. Biol. Chem. 273, 28238–28246; Adam, L.,
Vadlamudi, R., Mandal, M., Chernoff, J., and Kumar, R.
(2000) J. Biol. Chem. 275, 12041–12050). To study the role
of Pak1 in the regulation of motility and growth of
breast epithelial cells, we developed human epithelial
MCF-7 clones that overexpressed the kinase-active
T423E Pak1 mutant under an inducible tetracycline pro-
moter or that stably expressed the kinase-active
H83L,H86L Pak1 mutant, which is deficient in small
GTPase binding sites. The expression of both T423E and
H83L,H86L Pak1 mutants in breast epithelial cells was
accompanied by increased cell motility without any ap-
parent effect on the growth rate of cells. The T423E Pak1
mutant was primarily localized to filopodia, and the
H83L,H86L Pak1 mutant was primarily localized to ruf-
fles. Cells expressing T423E Pak1 exhibited a regulat-
able stimulation of mitogen-activated protein kinase
and Jun N-terminal kinase activities. The expression of
kinase-active Pak1 mutants significantly stimulated an-
chorage-independent growth of cells in soft agar in a
preferential mitogen-activated protein kinase-sensitive
manner. In addition, regulatable expression of kinase-
active Pak1 resulted in an abnormal organization of
mitotic spindles characterized by appearance of multi-
ple spindle orientations. We also provide evidence to
suggest a close correlation between the status of Pak1
kinase activity and base-line invasiveness of human
breast cancer cells and breast tumor grades. This study
is the first demonstration of Pak1 regulation of anchor-
age-independent growth, potential Pak1 regulation of
invasiveness, and abnormal organization of mitotic
spindles of human epithelial breast cancer cells.
Breast cancer is one of the most common malignancies in the
United States, affecting one in nine women. Overexpression of
the human epidermal growth factor receptor-2 (HER 2,1 also
known as c-ErbB2) is associated with increased progression
and metastasis, an aggressive clinical course, and decreased
disease-free survival in human breast cancer patients (1). Ac-
cumulating evidence suggests that in addition to HER 2 over-
expression, the heregulin (HRG; a combinatorial ligand for
HER 3, HER 4) pathway is involved in the progression of breast
cancer cells to a more invasive phenotype (2–5). Exposure of
cells to growth factors induces cytoskeleton reorganization,
lamellipodia formation, and membrane ruffling; such changes
contribute to increased cell migration and invasion (3, 6). Mem-
bers of Rho family of the small GTPases Rac1, Cdc42, and RhoA
have been implicated in the regulation of cytoskeletal rear-
rangements; RhoA is involved in the maintenance of actin
stress-fibers and focal adhesion points; Rac1 in the formation of
lamellipodia and membrane ruffles (7); and Cdc42 in the for-
mation of peripheral actin microspikes and filopodia (8). The
small GTPases also regulate gene expression: Cdc42 and Rac1
activate Jun N-terminal kinase and p38 mitogen-activated pro-
tein kinase (p38 MAPK) pathways (9). Thus GTPases Rac1,
Cdc42, and Rho are implicated in cellular transformation (10,
11). Cdc42 and Rac1 family members also activate extracellu-
lar signal-regulated protein kinases and ternary-complex fac-
tor (12). The signaling pathway by which the small GTPases
regulate their diverse cellular functions is an evolving area of
investigation.
In mammalian cells, p21-activated kinases (Paks) are iden-
tified as one target of the small GTPases Cdc42 and Rac1, and
binding of GTP-bound GTPases to Pak1 stimulates its kinase
activity via autophosphorylation (13). Expression of the acti-
vated T423E Pak1 mutant triggers the formation of lamellipo-
dia, dissolution of stress fibers, and dissolution of focal adhe-
sion complexes in fibroblast cells (14, 15). Expression of
another kinase-active Pak1 mutant with a mutation in GTPase
binding sites, H83L,H86L, supports the formation of actin ruf-
fles (16).
The Pak1 contains five potential SH3 domains (16, 17). In
addition to kinase activity, SH3 domains of Pak1 have been
implicated in cytoskeletal changes and Pak1 localization, prob-
ably via their interaction with adapter molecules such as Nck,
guanine nucleotide factor PIX, and paxillin (18–20). Pak1 ki-
nase activity is essential for the formation of polarized lamel-
lipodia at the leading edge (21) and for actin-myosin-mediated
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cytoskeletal changes involving myosin light chain phosphoryl-
ation (22). Pak1 also activates a number of signaling pathways,
including p38 MAPK, extracellular signal-regulated protein
kinase, Jun N-terminal kinase, and NF-kB (12, 23). Expression
of the kinase-dead K299R Pak1 mutant blocks the transforma-
tion of Rat1 fibroblast by Ras (24) and cooperative extracellular
signal-regulated protein kinase activation by Ras, Rho, and
Rac1 GTPases, suggesting that Pak1 plays a role in the cell
transformation and extracellular signal-regulated protein ki-
nase activation (25).
Treatment of noninvasive human breast epithelial MCF-7
cells with HRG induces Pak1 kinase activity and motility (4).
To further understand the role of Pak1 in the regulation of
motility and growth of breast epithelial cells, we established
stable breast cancer cell lines expressing T423E and
H83L,H86L Pak1 mutants. The expression of kinase-active
Pak1 mutants was accompanied by a significant stimulation of
motility, invasiveness, and anchorage-independent growth of
epithelial cells. The Pak1-linked enhanced ability of cells to
grow in soft agar was preferentially sensitive to a specific
MAPK inhibitor compared with p38 MAPK inhibitor, implying
that Pak1 regulates anchorage-independent growth of epithe-
lial cells via a MAPK kinase pathway.
MATERIALS AND METHODS
Cell Cultures and Reagents—MCF-7 human breast cancer cells (4)
were maintained in DMEM/F-12 (1:1) supplemented with 10% fetal calf
serum. Antibodies were purchased from the following companies: Pak1
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); Vinculin from
Sigma; anti-HA from Roche Molecular Biochemicals; phospho-MEK1,
phospho-p42/44 MAPK, and phospho-p38 MAPK from New England
Biolabs. Inhibitors SB203580 and PD980599 were purchased from
Calbiochem.
Constructs and Production of Stable Cell Lines—MCF-7 cells were
sequentially transfected with pTak (Teton vector, CLONTECH) plus
pNeomycin plasmid (pNeo) and pTet-Splice-HA-Pak1 (T423E) (21) and
hygromycin plasmid (pHyg, CLONTECH) using the calcium phosphate
method. Forty-eight hours post transfection, cells were selected in me-
dium containing 1000 mg/ml G418 (to retain the tetracycline-VP16
transactivator) and 200 mg/ml hygromycin (to select for the T423E
Pak1-regulated expression vector). Stable cells expressing H83L,H86L
Pak1 were transfected and selected with hygromycin. Expression of
Pak1 mutants was verified by immunoblotting using anti-HA mAb.
Cell Migration and Immunofluorescence Assays—The cell migration
assays were performed using the Boyden chambers using a confocal
microscope (4). T423E cells were induced for 24 h with doxycycline (1
mg/ml) in DMEM containing 10% serum. Cells grown in the absence of
doxycycline were used as control. After a short treatment with trypsin,
the cells were washed, resuspended in DMEM/F-12 plus 0.1% bovine
serum albumin in the presence or absence of doxycycline, and loaded on
the upper well of a Boyden chamber at a concentration of 20,000
cells/well. The lower side of the separating filter was coated with che-
moattractant (a thick layer of 1:2 diluted Matrigel (Life Technologies,
Inc.) in serum-free DMEM/F-12. The number of cells that successfully
migrated through the filter and invaded the 2-mm Matrigel layer in
order to spread as well as those that remained on the upper side of the
filter were counted by confocal microscopy after staining with pro-
pidium iodide (Sigma). The percentage of migrating cells compared with
the total number of cells was recorded and represents the mean 6 S.E.
of triplicate wells from three separate experiments. For co-staining of
filamentous actin and HA-tagged Pak1, 0.1 mM Alexa 546-conjugated
phalloidin was included during incubation with the fluorescein isothio-
cyanate-goat anti-mouse secondary antibody. Slides were mounted and
analyzed by a Zeiss-LSM inverted microscope or by confocal microscopy.
Cell Proliferation and Soft Agar Assays—Cell proliferation assays
were performed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide (MTT) dye method as described (4). Colony growth
assays were performed as described previously (26). Briefly 1 ml of
solution of 0.6% Difco agar in DMEM supplemented with 10% FBS with
insulin was layered onto 60 3 15-mm tissue culture plates. MCF-7 cell
(10,000 cells) were mixed with 1 ml of 0.36% Bactoagar solution in
FIG. 1. Characterization of kinase-active Pak1-expressing cell lines. A, schematic representation of Pak1 mutants (T423E and
H83L,H86L) used in the study. PBD, p21 GTPase binding domain. B, T423E-expressing MCF-7 cells were treated with increasing concentrations
of Dox, and induction of T423E Pak1 was analyzed by immunoblotting with HA mAb. Lysates from stable clones expressing HA-H83L,H86L Pak1
were loaded in the last lane. A duplicate set of blots was immunoblotted with a Pak1 antibody. C, kinetics of HA-Pak1 expression was analyzed
by treating cells at various time points with 1 mg/ml of Dox and analyzed by Western blot using a mouse anti-HA mAb. The blot was reprobed with
an anti-vinculin antibody as a loading control. D, an equal amount of protein from serum-starved cells was immunoprecipitated with an anti-HA
antibody, and kinase activity of exogenously expressed Pak1 mutants was analyzed by in vitro kinase assay using myelin basic protein as a
substrate. E, migration of T423E- and H83L,H86L-expressing clones was analyzed using a modified Boyden chamber as described under “Materials
and Methods.” Results shown are representative of three separate experiments.
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DMEM prepared in a similar manner and layered on top of the 0.6%
Bactoagar layer. Plates were incubated at 37 °C in 5% CO2 for 21 days.
For cells expressing T423 Pak1, doxycycline (1 mg/ml) was added where
indicated. As a positive control, HRG 10 ng/ml was also included in the
medium. When indicated, some cultures were treated with MEK1/2
inhibitor PD980599 (10 mM) and p38 MAPK inhibitor SB203580 (10
mM).
Biochemical Assays—We have prepared the cell extracts and per-
formed immunoprecipitation, immunoblotting, kinase reactions, and
DNA-binding gel shift assays following the methods described by us
earlier (3–6).
Immunohistochemistry—Nine cases of 10% formalin-fixed, paraffin-
embedded human breast carcinoma samples was processed for peroxi-
dase anti-peroxidase immunohistochemical staining to reveal the Pak-1
expression. Briefly, the sections were deparaffinized with xylene and
rehydrated through graded ethanol. The sections were then incubated
with rabbit-anti-Pak-1 (1:50 dilution; Santa Cruz Biotechnology) for
2 h, goat anti-rabbit IgG (1:100 dilution, Sigma) for 1 h, and rabbit
peroxidase anti-peroxidase (1:200 dilution, Sigma) for 1 h at room
temperature. The sections were washed three times with PBS after
each incubation. Finally, the staining was visualized with diaminoben-
zidine-H2O2 and counterstained with hematoxylin. For specificity con-
trol, the sections were stained with the same concentration of normal
rabbit IgG in place of the primary antibody.
RESULTS AND DISCUSSION
Characterization of Inducible Expression of Kinase-active
T423E Pak1 in Epithelial Cancer Cells—To study the influence
of Pak1 kinase on the biology of epithelial breast cancer cells,
we established stable cell lines with inducible expression of the
activated form of Pak1 under the control of the tetracycline-
regulated promoter. We used the T423E Pak1 mutant, which
behaves as activated Pak1 kinase but retains its ability to bind
Cdc42 and Rac1 (16, 21). We also used another stable clone
expressing the H83L,H86L Pak1 mutant, which lacks the abil-
ity to bind Cdc42/Rac1 but behaves as an activated Pak1 kinase
(16, 21). These Pak1 mutants allowed us to differentiate the
effects that were caused by sequestering of Cdc42/Rac1, Pak1
kinase activity, or both.
To induce the expression of T423E Pak1, MCF-7 cells stable
transfected with Tet-T423E plasmid were treated with doxycy-
cline for various time intervals or with different doses of doxy-
cycline (Dox), and T423E Pak1 expression was analyzed by
Western blotting analysis using an anti-HA tag monoclonal
antibody. Doxycycline induced expression of T423E Pak1 pro-
tein in a dose- and time-dependent manner (Figs. 1, B and C).
The identity of the induced band as T423E Pak1 was also
confirmed by immunoblotting with an anti-Pak1 antibody. The
levels of induced expression of T423E Pak1 were 3–5 times
those of endogenous Pak1. To determine if the expressed pro-
tein was functional and retained its kinase activity, HA-tagged
T423E Pak1 was immunoprecipitated from cells grown in se-
rum-free conditions with an anti-HA mAb, and exogenously
expressed Pak1 kinase activity was measured by in vitro ki-
nase assay. Myelin basic protein was used as a substrate, and
signal was quantitated by a PhosphorImager (Molecular Dy-
namics, Inc., Sunnyvale, CA). As shown in Fig. 1D, Pak1 kinase
activity was also induced by doxycycline in a dose-dependent
manner. For subsequent studies, we used a 1 mg/ml dose of
doxycycline, which could effectively induce about 3-fold induc-
tion of T423E Pak1 protein and its kinase activity as compared
with endogenous Pak1 levels. The level of expression of
H83L,H86L Pak1 in stable clones was 5–6-fold that of vector-
transfected control cells. The kinase activity of H83L,H86L
Pak1, however, was lower than that of T423E Pak1 cells, tak-
ing into account the 3-fold lower expression of T423E Pak1
(Fig. 1D, compare lanes 4 and 6).
We next analyzed the influence of Pak1 expression on the
migration of MCF-7 cells using Boyden chamber assay. Vector-
transfected cells showed low motility (Fig. 1E). In contrast,
FIG. 2. A, Localization of kinase-active
Pak1 mutants. Vector-transfected or active
Pak1-expressing cells were co-stained with
Alexa 546-phalloidin to visualize F-actin-
containing structures and with an anti-HA
mAb to visualize the localization of active
HA-tagged Pak1 mutants. Yellow indicates
colocalization between the F-actin and Ha-
tagged Pak1 protein (arrows). T423E cells
were treated with or without doxycycline for
24 h to induce the expression of Pak1 mu-
tant. T423E Pak1 cells exhibited numerous
F-actin-containing filopodia (T423E 1 Dox),
and H83L,H86L Pak1-expressing cells ex-
hibited extensive membrane ruffling as com-
pared with control Tet vector-transfected
cells. The arrows indicate co-localization of
HA-tagged Pak1 with F-actin. Similar re-
sults were obtained in three separate exper-
iments. B, effect of kinase-active Pak1 ex-
pression on anchorage-independent growth
of MCF-7 cells. Anchorage-independent
growth potential of the active Pak1-express-
ing clones was measured by their ability to
form colonies on soft agar. HRG treatment
was used as a positive control. Similar re-
sults were seen on four independent experi-
ments. Error bars represent S.E. C, repre-
sentative photographs of soft agar colonies.
Results shown are representative of four in-
dependent experiments.
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induction of T423E Pak1 with doxycycline resulted in a signif-
icant increase in cell motility. HRG treatment was used as a
positive control. H83L,H86L Pak1 mutant also induced motil-
ity of epithelial cells to a level similar to that induced with HRG
treatment. Recently, it was shown that kinase activity affects
directional cell movement (21). Although both active mutants
(T423E Pak1 and H83L,H86L Pak1) stimulated cell migration,
the higher activity of T423E suggests that kinase activity and
its localization and interaction with other proteins also play a
role in increasing the migratory potential of MCF-7 cells.
Localization of T423E Pak1 and H83L,H86L Pak1—The sub-
cellular localization of active Pak1 mutants was visualized by
immunofluorescence staining for tagged HA and actin. MCF-7
cells expressing T423E and H83L,H86L Pak1 exhibited dis-
tinct actin localization. Cells expressing T423E Pak1 showed
the presence of filopodia, and HA-Pak1 was predominantly
localized at the cell periphery that corresponds to the filopodia
structures (Fig. 2A). Cells expressing T423E Pak1 showed very
few stress fiber compared with vector-transfected cells (Fig. 2A)
and exhibited scattered phenotype. Thirty to forty percent of
cells expressing T423E Pak1 generated a leading edge reminis-
cent of motile phenotype. In contrast, cells expressing
H83L,H86L Pak1 showed lower levels of filopodia or stress
fibers but exhibited extensive membrane ruffling to which HA-
Pak1 staining was localized. Formation and induction of actin-
containing structures, including filopodia, ruffles, and leading
edge, and dissolution of stress fibers by active kinase mutants,
which in turn loosen their contacts with the substratum, may
provide an advantage for the cells and may have contributed to
the increased migration observed in Boyden chamber assays
(Fig. 2A).
Increased Anchorage-independent Growth of MCF-7 Cells
Expressing Kinase-active Pak1 Mutants—Kinase-deficient
Pak1 can suppress transformation that is mediated by Ras,
Rho, and Rac1 (24, 25) in Rat1 cells but not in NIH3T3 cells,
suggesting that the transformation-blocking function of Pak1
depends on the cellular context. To examine the potential in-
fluence of regulatable expression of kinase-active Pak1 on the
growth characteristics of breast epithelial cancer cells, we
measured the growth rate and ability of cells to grow in an
anchorage-independent manner. Expression of kinase-active
Pak1 mutants had very little or no significant effect on the
growth rate of MCF-7 cells on plastic (data not shown). Kinase-
active Pak1 mutants did, however, significantly enhance the
ability of MCF-7 cells to form colonies on soft agar (Fig. 2B).
There was no difference in the number or size of colonies
between vector-transfected control cells and uninduced T423E-
expressing cells. Doxycycline-mediated increase in the level of
expression of T423E Pak1 was accompanied by a significant
reproducible enhancement of the ability of cells to form colonies
in soft agar comparable with that of the cells treated with HRG
as a positive control. Cells expressing H83L,H86L Pak1 also
exhibited a profound increase in ability to grow in an anchor-
age-independent manner (Fig. 2B). This finding contradicts an
earlier observation (24) showing the inability of H83L,H86L
Pak1 in Rat1 cells to form colonies in soft agar. It is possible
that these different results reflect the use of fibroblast versus
epithelial cells in these two studies.
Regulation of MAPK Signaling Pathways by T423E
Pak1—To study the biochemical basis of the increased ability of
MCF-7 cells to form colonies in soft agar, we analyzed the
signaling pathways activated in cells expressing T423E Pak1.
FIG. 3. Signaling pathways activated
by T423E and H83L,H86L Pak1 mu-
tants. MCF-7 cells expressing either vector
or Pak1 mutants were serum-starved for
24 h and induced to express T423E Pak1 by
treating cells with doxycycline (1 mg/ml) for
24 h. A, activation of signaling molecules
was measured by Western blotting using
phosphospecific antibodies. B, AP-1 binding
activity was measured as a measure of acti-
vation of JNK pathway by electrophoretic
mobility shift assay (upper panel) and Su-
pershift (arrowheads) assays with various
antibodies (bottom panel). C, kinetics of ac-
tivation of MEK1 and 42/44 MAPK kinases
by induction of T423E. Results shown are
representative of three separate experi-
ments with similar findings. -Fold induction
over control was calculated using the Sigma
Scan program. D, MEK1 inhibitor PD98059
significantly reduced active Pak1-mediated
anchorage-independent growth. Soft agar
colony assays were performed in the pres-
ence of p42/44 MAPK pathway inhibitor
(PD98059) and p38 MAPK kinase pathway
inhibitor (SB203580). Treatment with HRG
was used as a positive control. Results
shown are representative of three independ-
ent experiments.
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We used doxycycline to induce the expression of T423E Pak1
and analyzed the activation status of the signaling components
by blotting with phosphospecific antibodies. Both T423E and
H83L,H86L Pak1 mutants demonstrated increased p42/44
MAPK activity (2–4-fold) over vector-transfected cells. T423E
Pak1 mutant demonstrated a modest increase in the level of
p38 MAPK (1.6–2-fold, Fig. 3A). Both Pak1 mutants exhibited
increased AP-1-DNA binding activity, which was determined
by electrophoretic mobility shift assay (Fig. 3B, upper panel).
Results of supershift experiments using specific antibodies that
recognize specific components of the AP-1 complex suggested
that the increased AP-1 DNA binding activity was caused pri-
marily by c-Jun and JunD transcription factors (Fig. 3B, lower
panel). The exhibition of similar patterns of super shifts of AP-1
DNA complex by both Pak1 mutants suggested the possibility
of regulation of c-Jun and JunD transcription factors by the
Pak1 pathway. To further characterize the regulation of the
p42/44 MAPK pathway by Pak1, we used doxycycline to induce
T423E Pak1 expression in MCF-7 as a function of time. Con-
sistent with the earlier results, p42/44 MAPK and its upstream
kinase MEK1/2 were activated in a time-dependent manner by
the induction of Pak1 (Fig. 3C). When vector-transfected cells
were exposed to doxycycline, the p42/44 MAPK pathway was
not induced (data not shown).
To address the possibility that activation of p42/44 MAPK
contributed to the anchorage-independent growth by active
Pak1 mutants, the soft agar experiment was repeated in the
presence or absence of PD98059, a specific MAPK inhibitor, or
SB203580, a specific p38 MAPK inhibitor. As illustrated in Fig.
3D, inclusion of a nontoxic dose of PD98059 blocked the T423E
Pak1-mediated increase in anchorage-independent growth; in-
clusion of SB203580 had a small inhibitory effect compared
with PD98059. Nonspecific inhibitory effects of PD98059 did
not cause the observed blockade effect of PD98059 on anchor-
age-independent growth, because it failed to suppress the an-
chorage-independent growth supported by HRG treatment
(Fig. 3D). These results suggest that Pak1 plays a role in
activating p42/44 MAPK. Although it is well accepted that
Pak1 activates Jun N-terminal kinase and p38 MAPK path-
ways, there are contradictory reports on whether Pak1 acti-
vates p42/44 MAPK (12, 23, 27). The use of different cell sys-
tems or the use of transient and inducible systems could have
caused the variation between the earlier reports and the re-
sults presented in this study. These results suggest that p42/44
MAPK may have a possible preferential role of supporting the
anchorage-independent growth of cells expressing kinase-ac-
tive T423E Pak1.
Active Pak1 Expression Leads to an Abnormal Organization
of Mitotic Spindles—Earlier studies with Pak homologues in
Saccharomyces cervisiae (Ste20) showed that Pak homologues
have a role in cytokinesis and in mitosis (28, 29). To determine
whether extended expression of the mammalian Pak1 homo-
logue affected cell cycle progression, we induced expression of
kinase-active Pak1 by treating MCF-7 cells expressing T423E
for 72 h with doxycycline. Cell cycle progression was analyzed
by fluorescence-activated cell sorting analysis, and there were
no significant differences between the cell cycle progression of
these treated cells and that of the control vector-transfected
cells (data not shown). We next examined whether prolonged
activation of Pak1 could influence the organization of mitotic
spindles and thus possibly contribute to anchorage-indepen-
dent growth via modifying the status of DNA ploidy and
genomic instability. To explore this possibility, MCF-7 cells
expressing Tet vector or T423E Pak1 were treated with doxy-
cycline for 72 h to induce the expression of active Pak1. Cells
were costained with monoclonal antibody against b-tubulin
(green) to mark spindles and polyclonal antibody against the
BTAK protein (red) to localize the centromere. The cells were
analyzed by confocal microscopy. As shown in Fig. 4, cells
expressing activated Pak1 exhibited multiple spindles with
several orientations and centromere spots (arrows); vector-
transfected cells did not show multiple spindles. For quantita-
tion, we scored 40 mitotic cells per field in eight different fields
(3 20) and counted cells exhibiting multiple spindles by ana-
lyzing each of them at a higher magnification. Induction of
kinase-active T423E Pak1 for 72 h resulted in the appearance
of multiple spindles in 11 6 1% of mitotic cells compared with
,2% in vector-transfected cells or T423E cells without doxycy-
cline. The multiple spindles in T423E Pak1-expressing MCF-7
cells could have been caused by defects in cytokinesis, but we
could not differentiate this possibility in the present study.
Additional studies are needed to delineate the potential role of
Pak1 in mitosis, including the effect of abnormal Pak activation
on cellular events responsible for segregation of mitotic
spindles.
Pak Expression and Breast Cancer—Since HRG activates
Pak1 activity and breast cancer progression (3–6), we hypoth-
esized that Pak1 expression and activity may be closely asso-
ciated with the invasive phenotypes of breast cancer cells. To
explore this possibility, we analyzed the level of Pak1 expres-
sion and activity in small numbers of grade II and grade III
breast tumor biopsies. As shown in Fig. 5A, there was a signif-
icant increase in the expression and kinase activity of Pak1 in
grade III tumors, as compared with grade II tumors (4). Inter-
estingly, increased expression of another band at 55 kDa was
also observed in grade III tumors. Since Pak1 antiserum is also
FIG. 4. Prolonged expression of Pak1 leads to appearance of
multiple spindles. MCF-7 cells expressing Tet vector (a and b) or
Tet-T423E construct (c–g) were treated with Dox for 72 h. Cells were
co-stained with anti-b1-tubulin mAb (green) and anti-BTAK antibody
(red) and analyzed by confocal microscopy. Two vector-transfected cells
are shown: one in metaphase (upper cell) and one in anaphase (lower
cell) sectioned at one 400-nm interval (a and b). Note the typical local-
ization of BTAK at the level of each spindle pole and a quasiplanar
distribution of the symmetric spindles. By contrast, cells expressing the
active T423E Pak1 showed three (c–e) or multiple (f and g) spindles that
form different angles between them (one antero-superior, one latero-
posterior, and one supero-posterior (d). Multiple spindles with different
orientations are shown in another example of the effect of T423E Pak-1
induction (f and g).
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known to react with the Pak2 isoform, we believe that Pak2
may also be elevated in grade III samples.
We also examined the level of endogenous Pak1 activity in a
panel of invasive and noninvasive breast cancer cell lines
grown in complete medium supplemented with 10% fetal calf
serum. Invasive breast cell lines (MDA-MB435, MDA-MB231)
exhibited a significant elevation in the level of Pak activity as
compared with noninvasive breast cancer cell lines (MDA-453,
BT-474, and MCF-7) (Fig. 5B). Although Pak1 expression was
observed in MCF-7 cells, the level of Pak1 kinase activity in
MCF-7 cells was significantly lower as compared with its levels
higher in invasive cells, suggesting that Pak activity rather
than the amount Pak1 may be responsible for the phenotype.
Similarly, grade III tumors (four out of five) exhibited an ele-
vation in the level of Pak kinase activity compared with grade
II tumors. There was no direct correlation between the expres-
sion level of Pak1 protein and its activity. It is possible that the
Pak1 kinase activity in tumor cells may be stimulated by mu-
tation or signaling pathways or autocrine/paracrine growth
factors. Taken together, these observations support the notion
that Pak1 activity rather than the expression of Pak1 protein
may be closely related with the invasiveness of breast cancer.
We next analyzed the expression of Pak1 in a panel of tumor
biopsies by immunohistochemical staining. As shown in Fig. 5
(C–H), there were low levels of Pak1 immunoreactivity in low
grade tumors (F, G). In contrast, poorly differentiated ductal
carcinomas of the breast (documented as grade III) demon-
strated a significant intense Pak1 staining (Figs. 5, C–E). Fig.
5F displays grade 2 breast carcinoma showing low level stain-
ing for Pak1. A larger study is needed to further establish the
validity of these new results.
In summary, our findings demonstrated the ability of Pak1
activity to stimulate the growth of breast epithelial cancer cells
in an anchorage-independent manner and to promote an ab-
normal organization of mitotic spindles. We also provide new
evidence to suggest a close relationship between the levels of
Pak1 expression and activity Pak1 and invasive phenotypes of
human breast cancer cell lines and tumor grades.
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FIG. 5. Levels of Pak1 expression and activity in human breast cancer cell lines and tumors. A, Pak1 levels and activity in breast
tumors. Breast tumor lysates (4) were analyzed by Western blotting for Pak1 expression (upper panel) and subsequently reprobed with a vinculin
antibody as a loading control (middle panel). Tumor lysates were immunoprecipitated with a Pak1 Ab and assayed for in vitro Pak1 kinase activity
(bottom panel). Quantitation of Pak1 kinase activity is shown as -fold change. B, status of endogenous Pak1 expression was analyzed by
immunoblotting in a panel of breast cancer cells grown in complete medium supplemented with 10% fetal calf serum (upper panel). Pak1 was
immunoprecipitated, and kinase activity was determined by in vitro kinase assay using myelin basic protein as a substrate (bottom panel).
Quantitation of Pak1 kinase activity is shown as -fold change. C–H, immunohistochemical demonstration of Pak1 in breast tissue samples. C–E,
are invasive poorly differentiated ductal carcinomas of the breast (documented as grade III). All show very strong positively for Pak1. F, grade
2-breast carcinoma showing low level staining for PAK1. E, ductal epithelial hyperplasia with a low level of Pak1 staining. H, negative control of
section adjacent to stained with normal rabbit IgG in place of the primary antibody. The sections were stained with the peroxidase anti-peroxidase
method and counterstained with hematoxylin.
Pak1 Regulation of Anchorage-independent Growth 36243
 by guest on M
arch 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
REFERENCES
1. Slamon, D. J., and Clark, G. M. (1988) Science 240, 1795–1798
2. Tang, C. K., Perez, C., Grunt, T., Waibel, C., Cho, C., and Lupu, R. (1996)
Cancer Res. 56, 3350–3358
3. Adam, L., Vadlamudi, R., Kondapaka, S. B., Chernoff, J., Mendelsohn, J., and
Kumar, R. (1998) J. Biol. Chem. 273, 28238–28246
4. Vadlamudi, R., Adam, L., Tseng, B., Costa, L., and Kumar, R. (1999) Cancer
Res. 59, 2843–2846
5. Vadlamudi, R., Adam, L., Talukder, A., Mendelsohn, J., and Kumar, R. (1999)
Oncogene 18, 7253–7264
6. Adam, L., Vadlamudi, R., Mandal, M., Chernoff, J., and Kumar, R. (2000)
J. Biol. Chem. 275, 12041–12050
7. Ridley, A. J, Paterson, H. F. Johnston C. L. Diekmann, D., and Hall A. (1992)
Cell 70, 401–410
8. Kozma., R., Ahmed, S., Best, A., and Lim, L. (1996) Mol. Cell. Biol. 16,
5069–5080
9. Coso, O., Chiariello, M., Yu, J. C., Teramoto, H., Crespo, P., Xu, N., Miki, T.,
and Gutkind, J. S. (1995) Cell 81, 1137–1146
10. Qiu. A, Chen, J., McCormick, F., and Symons, M. (1992) Proc. Natl. Acad. Sci.
U. S. A. 92, 11781–11781
11. Qiu. A, Chen J., Kir, D., McCormick, F., and Symons, M. (1995) Nature 374,
457–459
12. Frost, J. A., Steen, H., Shapiro, P., Lewis, T., Ahn, N., Shaw, P. E., and Cobb,
M. H. (1997) EMBO J. 16, 426–6438
13. Manser, E., Leung, T., Salhuddin, H., Zhao, Z. S., and Lim, L. (1994) Nature
367, 40–46
14. Zhao, Z., Manser, E., Chen, X., Chong, C. Leung T., and Lim, L (1998) Mol.
Cell. Biol. 18, 2153–2163
15. Manser, E., Loo, T. H., Koh C. G., Zhao, Z. S., Chen, X. Q., Tan, L., Tan, I.,
Leung, T., and Lim, L. (1998) Mol. Cell 1, 183–192
16. Sells, M. A., Knaus, U. G., Bagrodia, S., Ambrose, D. M., Bakoch, G. M., and
Chernoff, J. (1997) Curr. Biol. 7, 202–210
17. Pawson, T., and Scott, J. D. (1998) Science 278, 2075–2080
18. Frost, J. A., Khokhlatchev, A., Stippec, S., White, M. A., and Cobb, M. H. (1998)
J. Biol. Chem. 273, 28191–28198
19. Dharmawardhane, S., Sanders, L. C., Martin, S. S., Daniels, R. H., and
Bokoch, G. M. (1997) J. Cell Biol. 138, 1265–1278
20. Turner, C. E., Brown, M. C., Perrotta, J. A., Riedy, M. C., Nikolopoulos, S. N.,
McDonald, A. R., Bagrodia, S., Thomas, S., Leventhal, P. S. (1999) J. Cell
Biol. 145, 851–863
21. Sells, M. A., Boyd, J. T., and Chernoff, J. (1999) J. Cell Biol. 145, 837–849
22. Sanders L. C., Mastsumura, F., Bokoch, G. M., and de Lanerolle, P. (1999)
Science 283, 2083–2085
23. Bagrodia, S., Derijard, B., Davis, R. J., and Cerione, R. A. (1995) J. Biol. Chem.
270, 27995–27998
24. Tang, Y., Chen, Z., Ambrose, D., Liu, J., Gibbs, J. B., Chernoff, J., and Field,
J. (1997) Mol. Cell. Biol. 17, 4454–4464
25. Tang, Y., Yu, J., and Field, J. (1999) Mol. Cell. Biol. 19, 1881–1891
26. Cox, A. D., and Der, C. J. (1994) Methods Enzymol. 238, 277–294
27. Frost, J. A., Xu, S., Hutchison, M. R., Marcus, S., and Cobb, M. H. (1996) Mol.
Cell Biol. 16, 3707–3713
28. Cvrckova, F., De Vigilio, C., Manser, E., Pringle, J. R., and Nasmyth, K. (1995)
Genes Dev. 9, 1817–1830
29. Wu, C., Lytvyn, V., Thomas, D. V., and Leberer, E. (1997) J. Biol. Chem. 272,
30623–30626
Pak1 Regulation of Anchorage-independent Growth36244
 by guest on M
arch 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Aysegul Sahin, Jonathan Chernoff, Mien-Chie Hung and Rakesh Kumar
Ratna K. Vadlamudi, Liana Adam, Rui-An Wang, Mahitosh Mandal, Diep Nguyen,
Cancer Cells
BreastGrowth and Abnormal Organization of Mitotic Spindles in Human Epithelial 
Regulatable Expression of p21-activated Kinase-1 Promotes Anchorage-independent
doi: 10.1074/jbc.M002138200 originally published online August 16, 2000
2000, 275:36238-36244.J. Biol. Chem. 
  
 10.1074/jbc.M002138200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/275/46/36238.full.html#ref-list-1
This article cites 29 references, 18 of which can be accessed free at
 by guest on M
arch 13, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
